Kasabwala K.,Wise G.J. . .Varicella-zoster virus and urologic practice: A case-based review. Canadian Journal of Urology, 29900816(3) : 9301-9306.
Freer G.,Pistello M.,April 2018 . .Varicella-zoster virus infection: Natural history, clinical manifestations, immunity and current and future vaccination strategies. ” New Microbiologia, 29498740(2) : 95-105.
Heineman T.C. .2019 .Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine. ” Current Opinion in Immunology, 31003070 : 42-48.
Dayan R.R.,Peleg R. .2017 .Herpes zoster-typical and atypical presentations. Postgraduate Medicine, 1335574(6) : 567-571.
Marin M. .2021 .Communicability of varicella before rash onset: a literature review. ” Epidemiology and Infection, 149 : .
Yang Q. .2021 .Herpes zoster vaccine live and risk of stroke among Medicare beneficiaries: A population-based cohort study. ” Stroke, 52(5) : 1712-1721.
Cadogan S.L. . .Prevalence of and factors associated with herpes zoster in England: A cross-sectional analysis of the Health Survey for England.” BMC Infectious Diseases. , 22(1) : 513.
Kovac M. .2018 .Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials. Vaccine, 02(12) : 1537-1541.
Farahat F. .2024 .Epidemiology of herpes zoster in National Guard Hospitals in Saudi Arabia: A 6-year retrospective chart review study. ” Frontiers in Public Health, 1479640 : 1479640.
Lal H. .2015 .Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. ” New England Journal of Medicine, 372(22) : 2087-2096.
Godeaux O. .2016 .Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. ” Human Vaccines and Immunotherapeutics, 1265715(5) : 1051-1058.
Al-Khalidi T.,November 2022 .2022 .Knowledge, attitudes and practices of the United Arab Emirates population towards herpes zoster vaccination: A cross-sectional study. ” Human Vaccines and Immunotherapeutics, 2073752(5) : 2073752.
Alfandi N. .2024 .Assessment of knowledge, attitudes and practices of herpes zoster vaccination among the general population in Al-Ahsa, Saudi Arabia. ” Journal of Healthcare Sciences, 40102(2024) : 11-22.
Alqahtani A.S.,November 2017 .2017 .Knowledge and attitudes of Saudi populations regarding seasonal influenza vaccination. ” Journal of Infection and Public Health, 03(6) : 897-900.
Ghamri R.A. .2020 .Factors influencing adult immunization practices. ” Medical Science, 24(106) : 4453-4462.
Almalki M. . .Knowledge, attitude and practice regarding herpes zoster vaccination among PHC patients in the central region of Saudi Arabia: A cross-sectional study. International Journal of Medicine in Developing Countries, 8(2024) : 1724738261-2249.
Alghofaili M. . .Barriers to herpes zoster vaccine uptake: evaluating knowledge, attitudes and practices in Saudi communities. International Journal of Medicine in Developing Countries, 9(2025) : 1740565049-687.
Dooling K.L. .2018 .Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. ” MMWR Morbidity and Mortality Weekly Report, 67 : 103-108.
.2023 .. Herpes zoster vaccines, : .
Al-Khowailed M.S.,April 2024 . .Public perception in Saudi Arabia toward herpes zoster and its vaccination: A cross-sectional study. ” Cureus, 16(4) : .
Oxman M.N. . .Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence. ” Journal of the American Osteopathic Association, 19553630(suppl) : S13-S17.
Alotaibi N.A. .2021 .Physicians' knowledge and attitudes toward adult immunization in Saudi Arabia.” Human Vaccines and Immunotherapeutics. , 1936867(10) : 3656-3663.
Andre F.E. . .Vaccination greatly reduces disease, disability, death and inequity worldwide. ” Bulletin of the World Health Organization, 86(2008) : 140-146.